Abstract
Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease with multisystem involvement that mainly affects young women; however, there is a distinct phenotype of late-onset SLE, generally defined in the literature, with onset after the age of 50 years, with a milder course, a group in which renal involvement is atypical, worsening clinical outcomes.
Objective: It is important to know this atypical presentation of the disease to include it as a differential diagnosis in patients and to make a timely diagnosis to avoid adverse clinical outcomes.
Case presentation: We present the case of a 57-year-old man who consulted with deterioration of his functional class associated with edema, with recent history of deep vein thrombosis and arterial hypertension, laboratory tests showed elevated azotemia, moderate metabolic acidosis, proteinuria in nephrotic range with glomerular hematuria, low serum albumin levels and positive ANA (antinuclear antibodies).
Discussion and conclusion: Renal biopsy results indicated membranoproliferative glomerulonephritis with subendothelial immune complex deposits and “full house” immunofluorescence pattern. Rapidly progressive glomerulonephritis (RPGN) was considered as the initial manifestation of late-onset SLE, requiring renal replacement therapy. The patient received treatment with high-dose intravenous steroid and cyclophosphamide, without further deterioration of his clinical status or renal function; however, the patient continued to require hemodialysis.
References
Kang JH, Park DJ, Lee KE, Lee JS, Choi YD, Lee SS. Comparison of clinical, serological, and prognostic differences among juvenile-, adult-, and late-onset lupus nephritis in Korean patients. Clin Rheumatol. 2017;36(6):1289-95. https://doi.org/10.1007/s10067-017-3641-6
Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guidelines for screening, treat- ment, and management of lupus nephritis. Arthritis Care Res. 2012;64:797-808. https://doi.org/10.1002/acr.21664
Medhat BM, Behiry ME, Sobhy N, Farag Y, Marzouk H, Mostafa N, et al. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort. Clin Rheumatol. 2020;39(2):435-42. https://doi.org/10.1007/s10067-019-04776-y
Xu YX, Tan Y, Yu F, Zhao MH. Late onset lupus nephritis in Chinese patients: classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Lupus. 2011;20(8):801-8. https://doi.org/10.1177/0961203310397563
Sato VAH, Marques IDB, Goldenstein PT, Carmo LPF, Jorge LB, Titan SMO, et al. Lupus nephritis is more severe in children and adolescents than in older adults. Lupus. 2012;21:978-83. https://doi.org/10.1177/0961203312443421
Khan A, Sawant T, Deen Z, Humayun W, Humayun Y. Systemic lupus erythematosus in the elderly that debuts with an organic manifestation of lupus nephritis. Cureus. 2022;14(9):e28746. https://doi.org/10.7759/cureus.28746.
Komolafe OO. Rapidly progressive glomerulonephritis: a wild card manifestation of lupus nephritis. Saudi J Kidney Dis Transpl. 2018;29(2):443-51. https://doi.org/10.4103/1319-2442.229293.
Austin HA, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 1994;45(2):544-50. https://doi.org/10.1038/ki.1994.70
Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res. 2012;64(6):797-808. https://doi.org/10.1002/acr.21664
Dooley MA, Aranow C, Ginzler EM. Review of ACR renal criteria in systemic lupus erythematosus. Lupus. 2004;13(11):857-60. https://doi.org/10.1191/0961203304lu2023oa
Rovenský J, Tuchynová A. Systemic lupus erythematosus in the elderly. Autoimmun Rev. 2008;7(3):235-9. https://doi.org/10.1016/j.autrev.2007.11.014
González Naranjo LA, Ramírez Gómez LA. Lupus eritematoso sistémico de inicio tardío. Rev Colomb Reumatol. 2008;15(3):168-85. http://www.scielo.org.co/pdf/rcre/v15n3/v15n3a04.pdf
Boddaert J, Huong DLT, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine. 2004;83(6):348-59. https://doi.org/10.1097/01.md.0000147737.57861.7c
Ramos-Casals M, García-Carrasco M, Brito MP, López Soto A, Font J. Autoimmunity and geriatrics: clinical significance of autoinmune manifestations in the elderly. Lupus. 2003;12(5):341-55. https://doi.org/10.1191/0961203303lu383ed
Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity. 2005;38(7):507-18. https://doi.org/10.1080/08916930500285857
Padovan M, Govoni M, Castellino G, Rizzo N, Fotinidi M, Trotta F. Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. Rheumatol Int. 2007;27(8):735-41. https://doi.org/10.1007/s00296-006-0284-3
Hennemann Sassi R, Hendler JV, Fagundes Piccoli G, Aline Gasparin A, Mendoca da Silva Chakr R, Tavares Brenol JC, et al. Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus. Clin Rheumatol. 2017;36(1):89-95. https://doi.org/10.1007/s10067-016-3478-4
Delfino J, Dos Santos TA, Skare TL. Comparison of lupus patients with early and late onset nephritis: a study in 71 patients from a single referral center. Adv Rheumatol. 2020;60(1):5. https://doi.org/10.1186/s42358-019-0105-5
Kutky M, Aloudat S. Late-onset systemic lupus erythematosus with lupus nephritis in a 74-year-old male: A brief case and review. Can J Kidney Health Dis. 2018;5:205435811879339. https://doi.org/10.1177/2054358118793397.
Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine. 2006;85(3):147-56. https://doi.org/10.1097/01.md.0000224709.70133.f7
Arnaud L, Mathian A, Boddaert J, Amoura Z. Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment. Drugs Aging. 2012;29(3):181-9. https://doi.org/10.2165/11598550-000000000-00000
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.